Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
06/2011
06/08/2011EP2330201A1 Methods of synthesizing heteromultimeric polypeptides in yeast using a haploid mating strategy
06/08/2011EP2330198A1 IL-1 related polypeptides
06/08/2011EP2330197A2 Antagonistic selective binding agents of osteoprotegerin binding protein
06/08/2011EP2330196A2 Method for isolation of soluble polypeptides
06/08/2011EP2330195A2 Method for isolation of soluble polypeptides
06/08/2011EP2330193A1 Improved antibody molecule
06/08/2011EP2330192A1 Polypeptides and polynucleotides from coagulase-negative staphylococci
06/08/2011EP2330188A1 Circovirus sequences associated with porcine wasting disease (PWD)
06/08/2011EP2330132A1 Antibodies and pharmaceutical compositions containing same useful for inhibiting activity of metalloproteins
06/08/2011EP2330131A1 Antibodies against HER2 truncated variant CTF-611
06/08/2011EP2330130A1 Human monoclonal antibodies against CD20
06/08/2011EP2330129A2 Anti-TNF antibodies, compositions, methods and uses
06/08/2011EP2330128A1 Modified anti-heparin/pf4 complex antibody and hit antibody standard
06/08/2011EP2330123A2 HIV resistance genes
06/08/2011EP2330121A2 Binding moieties based on Shark IgNAR domains
06/08/2011EP2330120A2 Binding moieties based on Shark IgNAR domains
06/08/2011EP2330118A1 Gene conferring resistance to Phytophthora infestans (late-blight) in solanaceae
06/08/2011EP2330117A1 Genes of an otitis media isolate of nontypeable Haemophilus influenzae
06/08/2011EP2330116A1 Replikin peptides and uses thereof
06/08/2011EP2330115A1 Replikin peptides and uses thereof
06/08/2011EP2330111A2 Oligoribonucleotides and methods of use thereof for treatment of fibrotic conditions and other diseases
06/08/2011EP2329847A2 Use of an antibody or an immunotoxin that selectively binds to CD123 to impair hematologic cancer progenitor cells
06/08/2011EP2329844A1 Recombinant plasmodium falciparum merozoite surface proteins 4 and 5 and their use
06/08/2011EP2329837A1 Promoting bone growth
06/08/2011EP2329814A1 Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer
06/08/2011EP2329267A1 Mannose-6-phosphate-binding antibodies and their uses
06/08/2011EP2328934A1 T-cell receptor antibodies and methods of use thereof
06/08/2011EP2328933A1 Monoclonal anti-claudin 1 antibodies for the inhibition of hepatitis c virus infection
06/08/2011EP2328932A1 Anti-cd5 antibodies
06/08/2011EP2328931A1 Anti-hepcidin-25 selective antibodies and uses thereof
06/08/2011EP2328930A1 Antibodies directed against pyroglutamate monocyte chemoattractant protein-1 (mcp-1 n1pe)
06/08/2011EP2328929A2 Antigen-binding proteins that inhibit superantigens for the treatment of skin diseases
06/08/2011EP2328928A2 Conserved influenza hemagglutinin epitope and antibodies thereto
06/08/2011EP2328927A1 A method of binding bacterial lipopolysaccharides to a solid phase
06/08/2011EP2328926A1 Treatment of thrombocytopenia
06/08/2011EP2328917A1 Neuronal viability factor and use thereof
06/08/2011EP2328914A1 Prevention, treatment and diagnosis of p.gingivalis infection
06/08/2011EP2328909A1 Human catechol-o-methyltransferase (comt) assay
06/08/2011EP2328616A1 Compositions and methods for antibodies targeting complement protein c5
06/08/2011EP2328559A2 Novel antibody formulation
06/08/2011EP1817584B1 Antibodies and peptide antigens for producing antibodies having a selective binding specificity to bioactive intact parathyroid hormone (pth) 1-84
06/08/2011EP1573022B1 Nucleic acid and corresponding protein entitled 184p1e2 useful in treatment and detection of cancer
06/08/2011EP1485127B1 Administration of agents for the treatment of inflammation
06/08/2011EP1276765B1 Single-chain fertility hormones with variable lh activity
06/08/2011EP1276500B1 Blocking leukocyte emigration and inflammation by interfering with cd99/hec2
06/08/2011EP1069185B1 Humanized antibody against human tissue factor (tf) and process for constructing humanized antibody
06/08/2011EP0960936B1 Reconstituted human anti-hm1.24 antibody
06/08/2011CN1893979B Remedy for angitis
06/08/2011CN1852736B Immunoglobulin chimeric monomer-dimer hybrids
06/08/2011CN102089659A Abeta-oligomer measurement method
06/08/2011CN102089431A Functionalized polypeptides
06/08/2011CN102089327A Anti-PirB antibodies
06/08/2011CN102089326A Anti-IL-6/IL-6R antibodies and methods of use thereof
06/08/2011CN102089325A Peptides capable of binding to serum proteins and compounds, constructs and polypeptides comprising the same
06/08/2011CN102089324A Compositions and methods for the therapy and diagnosis of influenza
06/08/2011CN102089005A Staphylococcus aureus-specific antibody preparations
06/08/2011CN102089004A Pharmaceutical composition for treatment and prevention of cancer
06/08/2011CN102087279A Enzyme linked immunosorbent assay kit for combined diagnosis of gastrosis or evaluation of gastric cancer risks
06/08/2011CN102086230A Enzyme-linked immunosorbent assay kit for detecting melamine and application thereof
06/08/2011CN102086229A Method for detecting melamine and enzyme-linked immunosorbent assay kit special for same
06/08/2011CN102086228A ELISA (Enzyme Linked Immunosorbent Assay) Kit and application thereof
06/08/2011CN101570577B Monoclonal antibody for O, O-dimethoxythiophosphate pesticides
06/08/2011CN101381410B Rhodamine 123 artificial antigen synthesis, antibody preparation method and application
06/08/2011CN101352571B Medicament for treating encephalitis b and preparation method thereof
06/07/2011US7956173 Nucleic acids coding for humanized antibodies for binding sphingosine-1-phosphate
06/07/2011US7956164 Device for enhancing immunostimulatory capabilities of T-cells
06/07/2011US7956163 Antibodies that bind human OX2 receptors
06/07/2011US7956160 Freeze dried protein composition comprising manitol polymorphs which reconstitute quickly upon addition of diluent and provide solutions of high protein concentrations, with reduced formation of foam, effervescence, bubbles, aggregates and particulates
06/07/2011US7956038 GASP1: a follistatin domain containing protein
06/07/2011US7955807 Method of measuring PTX3 with high sensitivity
06/07/2011US7955600 Attenuated salmonella SP12 mutants as antigen carriers
06/07/2011US7955598 Therapeutic agent for chronic arthritides diseases of childhood-related diseases
06/07/2011US7955597 Anti-IL-6 antibodies, compositions, methods and uses
06/07/2011CA2471144C Polymorphs of sodium 4-[(4-chloro-2-hydroxybenzoyl)amino]butanoate
06/07/2011CA2441845C Ganglioside-associated recombinant antibodies and the use thereof in the diagnosis and treatment of tumours
06/07/2011CA2418422C Novel kallikrein gene
06/07/2011CA2321226C Genomic sequence of the 5-lipoxygenase-activating protein (flap), polymorphic markers thereof and methods for detection of asthma
06/07/2011CA2232245C Cellulases, the genes encoding them and uses thereof
06/07/2011CA2165949C Tuberculosis vaccine
06/03/2011WO2011066503A2 Compositions and methods for the diagnosis and treatment of tumor
06/03/2011WO2011066389A1 Targeted binding agents against b7-h1
06/03/2011WO2011065935A1 Methods for monoclonal antibody production
06/03/2011WO2011064664A2 T cell receptors specific for immunodominant ctl epitopes of hcv
06/03/2011WO2011064407A1 Agents for treating disease
06/03/2011WO2011064399A1 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
06/03/2011WO2011064398A1 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
06/03/2011WO2011064395A2 Inhibitors and antagonists of calcium channels in the treatment of asthma
06/03/2011WO2011064382A1 Improved amino acid sequences directed against human respiratory syncytial virus (hrsv) and polypeptides comprising the same for the prevention and/or treatment of respiratory tract infections
06/03/2011WO2011064257A2 Monospecific polypeptide reagents
06/03/2011WO2011064179A1 Marker protein for type 2 diabetes
06/03/2011WO2011063980A1 Anti-c5a binding moieties with high blocking activity
06/03/2011WO2011063523A1 Anti-clusterin antibodies and antigen binding fragments and their use to reduce tumor volume
06/03/2011WO2011022438A3 Cleavage sensitive antibodies and methods of use thereof
06/03/2011WO2011011453A3 Phenotyping tumor-infiltrating leukocytes
06/03/2011CA2782016A1 Monospecific polypeptide reagents
06/03/2011CA2782007A1 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
06/03/2011CA2782004A1 Humanized anti-il-10 antibodies for the treatment of systemic lupus erythematosus (sle)
06/03/2011CA2781887A1 Compositions and methods for the diagnosis and treatment of tumor
06/03/2011CA2781836A1 Agents for treating disease
06/03/2011CA2780520A1 Anti-c5a binding moieties with high blocking activity